| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.5 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.5 |